| Novartis Pharma Schweiz AG - Certican 0.25 mg, Tabletten | | 56238 | | 03 | | Certican 0.25 mg | | Tabletten | | L04AA18 | | Everolimus | | 21.04.2005 | | |
| | Composition | | everolimusum 0.25 mg, lactosum monohydricum 2.23 mg, hypromellosum, magnesii stearas, crospovidonum, lactosum 51.1 mg, E 321, pro compresso. | | Packungsbestandteile | | Tablets | | | | | Active Agent | Dose |
|---|
| Everolimus | 0.25 mg |
| | BAG: Active Agent | Dose |
|---|
| Everolimus | 0.25 mg |
| | | | Inactive agents | Dose |
|---|
| Crospovidonum | | | E 321 | | | Hypromellosum | | | Lactosum | 51.1 mg | | Lactose Monohydrate | 2.23 mg | | Magnesii Stearas | | | Pro Compresso | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 005 | 60 Tablet(s) | 145.64 | 174.80 | B | SL | No |
|
|
